[On the pharmacological action of phosphorylated pentaerythritol derivatives].
D000109:Acetylcholine / Q000633:toxicity*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002626:Chemistry, Pharmaceutical; D002794:Choline / Q000633:toxicity*; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D004285:Dogs; D004357:Drug Synergism; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006018:Glycols / Q000494:pharmacology* / Q000633:toxicity*; D007421:Intestine, Small / Q000187:drug effects; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects*; D009538:Nicotine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D015016:Yohimbine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D006018:Glycols; D010277:Parasympathomimetics; D015016:Yohimbine; D009538:Nicotine; D001285:Atropine; D002794:Choline; D000109:Acetylcholine
Sur l'activité pharmacologique de dérivés phosphorés du penta-erythritol.